← Leaderboards
Laventrice D Taylor
Morgan State University
$818,759
Attributed
$818,759
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $497.7K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,297,179 · 4
By mechanism
S06$556,259 · 2
R25$503,850 · 1
G12$237,070 · 1
Top collaborators
No co-investigators on record.
Most similar at Morgan State University
Same institution · by research overlap
- Christine F Hohmann$7,863,361
- Laventrice Taylor$280,363
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseGenetically Modified AnimalsDrug InteractionsDrug Adverse EffectTumor Necrosis Factor AlphaCell Cell InteractionWestern BlottingsAidsAllergic ArthritisApoptosisCell AdhesionDrug Screening /EvaluationEnzyme Linked Immunosorbent AssayImmunomodulatorsIn Situ HybridizationThalidomideT LymphocyteStatistics /BiometryStavudineFlow CytometryAntiviral AgentsHelper T LymphocyteHiv InfectionsCell Mediated Lymphocytolysis Test
Grant awards (11)
MBRS SCORE Program at Morgan State University$91,490
S06 · FY2006 · GM · contact PI
MBRS SCORE Program at Morgan State University$386,930
S06 · FY2005 · GM
ACT 5: MECHANISM OF TNF-ALPHA INHIBITORS IN HUMAN CELL LINES, AIDS$110,801
G12 · FY2005 · RR
ACT 5: MECHANISM OF TNF-ALPHA INHIBITORS IN HUMAN CELL LINES, AIDS$126,269
G12 · FY2004 · RR
MECHANISM OF IMMUNOTOXICITY OF THE AIDS THERAPEUTICS DDC AND D4T$174,086
R25 · FY2002 · GM
ANTI TNF ALPHA ACTIVITY OF THALIDOMIDE IN TNF ALPHA ARTHRITIS$0
S06 · FY2002 · GM
MECHANISM OF IMMUNOTOXICITY OF THE AIDS THERAPEUTICS DDC AND D4T$174,086
R25 · FY2001 · GM
ANTI TNF ALPHA ACTIVITY OF THALIDOMIDE IN TNF ALPHA ARTHRITIS$0
S06 · FY2001 · GM
MECHANISM OF IMMUNOTOXICITY OF THE AIDS THERAPEUTICS DDC AND D4T$155,678
R25 · FY2000 · GM
ANTI TNF ALPHA ACTIVITY OF THALIDOMIDE IN TNF ALPHA ARTHRITIS$77,839
S06 · FY2000 · GM
ANTI TNF ALPHA ACTIVITY OF THALIDOMIDE IN TNF ALPHA ARTHRITIS$0
S06 · FY2000 · GM